Cannabis Strategic Ventures Stock Beta
| NUGS Stock | USD 0.0001 0.00 0.00% |
Cannabis Strategic Ventures fundamentals help investors to digest information that contributes to Cannabis Strategic's financial success or failures. It also enables traders to predict the movement of Cannabis Pink Sheet. The fundamental analysis module provides a way to measure Cannabis Strategic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannabis Strategic pink sheet.
Cannabis |
Cannabis Strategic Ventures Company Beta Analysis
Cannabis Strategic's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Cannabis Strategic Beta | 1.34 |
Most of Cannabis Strategic's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannabis Strategic Ventures is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Cannabis Strategic Ventures has a Beta of 1.3438. This is 56.26% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The beta for all United States stocks is notably lower than that of the firm.
Cannabis Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cannabis Strategic's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Cannabis Strategic could also be used in its relative valuation, which is a method of valuing Cannabis Strategic by comparing valuation metrics of similar companies.Cannabis Strategic is currently under evaluation in beta category among its peers.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cannabis Strategic will likely underperform.
Cannabis Fundamentals
| Return On Asset | -0.2 | |||
| Profit Margin | (0.39) % | |||
| Operating Margin | (0.36) % | |||
| Current Valuation | 25.44 M | |||
| Shares Outstanding | 268.88 M | |||
| Price To Book | 113.91 X | |||
| Price To Sales | 0.26 X | |||
| Revenue | 14.6 M | |||
| Gross Profit | 2.78 M | |||
| EBITDA | (4.93 M) | |||
| Net Income | (5.64 M) | |||
| Cash And Equivalents | 402.8 K | |||
| Total Debt | 21.67 M | |||
| Current Ratio | 0.21 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (4.09 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 30 | |||
| Beta | 1.34 | |||
| Market Capitalization | 3.54 M |
About Cannabis Strategic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannabis Strategic Ventures's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannabis Strategic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannabis Strategic Ventures based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cannabis Pink Sheet Analysis
When running Cannabis Strategic's price analysis, check to measure Cannabis Strategic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabis Strategic is operating at the current time. Most of Cannabis Strategic's value examination focuses on studying past and present price action to predict the probability of Cannabis Strategic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabis Strategic's price. Additionally, you may evaluate how the addition of Cannabis Strategic to your portfolios can decrease your overall portfolio volatility.